Orca Bio
Series FOrca Bio is a privately held company based in United States, founded in 2016. The latest disclosed round is Series F ($250m), dated Jan 09, 2026. Institutional investors on record include Lightspeed Venture Partners.
United States · EST 2016
What is Orca Bio?
Orca Bio is a privately held company based in United States, founded in 2016. The latest disclosed round is Series F ($250m), dated Jan 09, 2026. Institutional investors on record include Lightspeed Venture Partners. Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed Orca Bio?
Who invested in Orca Bio?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| Lightspeed Venture Partners | Series F | $250m | Jan 09, 2026 |
What do founders ask about Orca Bio?
What is Orca Bio?
Orca Bio is a privately held company based in United States, founded in 2016. The latest disclosed round is Series F ($250m), dated Jan 09, 2026. Institutional investors on record include Lightspeed Venture Partners. Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was Orca Bio's last funding round?
Orca Bio's latest disclosed round is Series F at $250m (Jan 09, 2026).
Who invested in Orca Bio?
Orca Bio has 1 institutional investors on this page, including Lightspeed Venture Partners.
How does CrackTheDeck cover Orca Bio?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the Orca Bio card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.